Budget 2022: Income Tax Exemption For Covid-19 Compensation
Compensation received by individuals from their employers for treatment of illness related to Covid-19 pandemic will be exempt from tax. The relief will also be applicable for money received by an individual for treatment of any of their family members.
In June last year, the government had announced that income tax shall not be charged on the amount received by a taxpayer for medical treatment from employer or from any person for treatment of Covid-19 during FY20 and subsequent years.
This relief has now been proposed to be incorporated in the income tax law. The Finance Bill, 2022, has amended Section 56 of the Income Tax Act to exclude the receipt of such payment from the employer from the definition of income from other sources.
The second amendment to this section excludes money received from an employer by a family member of the deceased employee.
Such amount which is received by the family member in total should not exceed Rs 10 lakh and the person should have died due to Covid-19 pandemic.
If the amount due to the death is received by the family member within 12 months from the date of the death then the money will not be considered as income, the memorandum explaining the changes to Finance Bill, 2022, said.
The government has also formalised the earlier announcement that money received from an employer for their or their family member's treatment for Covid-19 will not be considered as perquisite.
For this purpose, Section 17(2) of the Income Tax Act has been amended to exclude such benefit from being defined as perquisite.
Perquisites mean benefits received by an employer above their salary/wage and includes housing rent allowance, dearness allowance, etc.
The changes will be applicable retrospectively from April 1, 2020. And so, the benefit will be available from assessment year 2020-21 and the subsequent assessment years.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.